Skip to main content

Table 3 Treatment characteristics and clinical outcomes of PD-associated peritonitis due to streptococci or other organisms in Australia 2003–2006.

From: Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases

Outcome

Streptococcal peritonitis

(n = 287 episodes)

Non-streptococcal peritonitis

(n = 3307 episodes)

P value

Treatment

   

   Change to 2nd antibiotic regimen

163 (57%)

1847 (56%)

0.8

   Time to 2nd antibiotic regimen

3 [1.75–5]

3 [2–5]

1.0

   Change to 3nd antibiotic regimen

37 (13%)

460 (14%)

0.7

   Time to 3rd antibiotic regimen

7.5 [5–9]

6 [4–10]

0.4

   Total antibiotic treatment duration

13 [8–18]

14 [8–20]

0.10

Hospitalisation

   

   Number (%)

212 (74%)

2292 (69%)

0.11

   Duration (days)

5 [3–10]

6 [3–12]

0.002

Catheter removal

   

   Number (%)

29 (10%)

746 (23%)

<0.001

   Time to occurrence (days)

7 [3–12]

6 [3–13]

0.8

Temporary haemodialysis

   

   Number (%)

9 (3%)

143 (4%)

0.3

   Time to occurrence (days)

3 [0.5–8]

6 [3–11.75]

0.08

   Duration (days)

36 [9–89]

68.5 [24.75–104.75]

0.12

Permanent haemodialysis

   

   Number (%)

25 (9%)

610 (18%)

<0.001

   Time to occurrence

8 [5–13]

7 [4–12]

0.4

Death

   

   Number (%)

4 (1%)

78 (2%)

0.3

   Time to death

7 [3–99.5]

13 [3.25–23.75]

0.7

  1. Results are expressed as number (%) or median days [interquartile range].